Personalized Tumor Neoantigen-Specific Vaccine Treatment

Dr. Saskia BiskupSaskia Biskup, MD, PhD, is a group leader at the Hertie Institute for Clinical Brain Research in Tuebingen, Germany.  She is the Managing Director of Cegat, and her company is developing a unique vaccine targeting cancer patients.The doctor says, "Changes in the genetic material (genome) of a single cell are responsible for the development